Can biosimilars help achieve the goals of US health care reform?

Can biosimilars help achieve the goals of US health care reform?

Ralph Boccia,1 Ira Jacobs,2 Robert Popovian,3 Gilberto de Lima Lopes Jr4 1Center for Cancers and Blood Disorders, Bethesda, MD, 2Global Medical Affairs, Pfizer Inc., New York, NY, 3US Government Relations, Pfizer Inc., Washington, DC, 4Sylvester Comprehensive Cancer Center, University of Miami, Miam...

Full description

Bibliographic Details
Main Authors: Boccia R, Jacobs I, Popovian R, de Lima Lopes Jr G
Format: Article
Language:English
Published: Dove Medical Press 2017-06-01
Series:Cancer Management and Research
Subjects:
Biosimilars
Patient Protection and Affordable Care Act
Healthcare reform
United States
Online Access:https://www.dovepress.com/can-biosimilars-help-achieve-the-goals-of-us-health-care-reform-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/can-biosimilars-help-achieve-the-goals-of-us-health-care-reform-peer-reviewed-article-CMAR

Similar Items